Study at a glance
How might vitamin D-related treatments affect blood-vessel linings?
The endothelium is the cell layer lining blood vessels. It helps control what passes through the vessel wall and how vessels respond to signals. This page compares laboratory tests of barrier strength with human trials of vessel responses. A tighter barrier and a vessel that widens more easily are different findings.
Did an active vitamin D-like drug reduce leakage in laboratory tests?
Paricalcitol, a drug similar to active vitamin D, reduced leakage through the lining of the main artery in rats with experimentally caused kidney disease. A vitamin D-deficient diet did not significantly alter leakage in this experiment. In human cells grown in the laboratory, the higher tested drug concentration strengthened the barrier and reduced disruption during a laboratory challenge. These experiments used cells from three donors. They did not show improved wound healing or fewer heart attacks in people.
Did vitamin D2 improve blood-vessel responses in people?
A six-month trial assigned 38 adults with kidney disease and low vitamin D to vitamin D2 or placebo. One test of small blood vessels in the skin improved, but other vessel tests did not show matching benefits. Recruitment was below the planned number, and follow-up was incomplete. A second trial assigned 93 overweight or obese adults without high blood pressure or established heart disease. After eight weeks, vitamin D2 raised blood levels but did not significantly improve widening of the upper-arm artery compared with placebo.
Do these findings establish a vitamin D treatment for heart and circulation problems?
The studies used different treatments, people and measurements. A positive cell result does not establish a treatment benefit, and a negative trial does not rule out every possible effect in other settings. None of these experiments established fewer heart attacks or strokes. They do not define a supplement dose, a vitamin D blood target or a proven treatment for heart and circulation problems.
Read the full article below ↓Vitamin D-related signalling can affect the endothelial cells lining blood vessels, but barrier strength and vessel relaxation are different outcomes. A laboratory study found that an active vitamin D analogue stabilised endothelial barriers. Human vitamin D2 trials produced different results for different vascular tests. For the detailed methods and appraisal, read Vitamin D, Endothelial Barriers and Vascular Function: Full Study.
What the barrier study tested
Vila Cuenca and colleagues studied paricalcitol, a synthetic active vitamin D analogue, in rats with surgically induced kidney disease and in cultured human umbilical-vein endothelial cells. This was not a trial of ordinary vitamin D3 supplements in patients. The endothelial function overview explains why both the lining’s barrier and its signalling functions matter.
The rat experiment compared kidney disease, vitamin D-deficient diet and treatment across eight groups of six to eight animals. Four of the 32 rats undergoing kidney surgery died during the operation. Healthy controls did not undergo sham surgery. Treatment lasted seven weeks, and some endpoint analyses contained fewer animals than the initial groups.
What changed in the laboratory
Kidney disease increased passage of Evans Blue dye into the aortic wall. Paricalcitol reduced this leakage and was associated with fewer gaps in the endothelial lining. The deficient diet did not significantly alter the leakage outcome in this model. That finding does not support a simple explanation in which low dietary vitamin D alone caused the barrier defect.
In cultured human cells, the higher paricalcitol concentration increased electrical resistance across the cell layer by about 8.4%, consistent with a tighter barrier. Microscopy showed stronger cell-junction staining. After a thrombin challenge, resistance fell by about 35% with the higher exposure versus 45% in controls. These are percentage drops from baseline, not percentages of clinical benefit.
Paricalcitol also improved recovery after electrical injury to the cultured layer. The experiments used cells from three healthy donors, and did not show better wound healing or fewer cardiovascular events in patients. Measurements did not establish a significant restoration of α-Klotho, a kidney-associated protein, but that does not exclude every contribution from this pathway.
A positive, but small, human trial
Dreyer and colleagues randomised 38 adults with non-diabetic chronic kidney disease and vitamin D deficiency to vitamin D2 or placebo for six months. The treated group had a better forearm skin response to acetylcholine, an endothelial-dependent stimulus. The trial measured local laser Doppler flux, not blood flow through the heart.
The response to sodium nitroprusside, an endothelium-independent vasodilator, did not significantly improve. Aortic stiffness and sublingual microcirculatory tests did not show matching benefits. The protocol had planned 80 participants and several vascular endpoints, and not all participants provided six-month data. The positive finding therefore needs confirmation in a larger trial.
A second human trial found no clear benefit
Borgi and colleagues randomised 93 overweight or obese adults with low vitamin D status but without hypertension or established cardiovascular disease; 84 completed follow-up. Eight weeks of vitamin D2 raised vitamin D concentrations without significantly improving brachial-artery endothelial-dependent vasodilation versus placebo. The journal later corrected Figure 3.
This null finding does not prove that vitamin D has no vascular effects under any circumstances. It shows that the tested replacement regimen did not establish benefit for this outcome in this selected population. The study differed from the kidney-disease trial in participants, duration and the part of the circulation measured.
What readers can conclude
The studies address different steps within heart and circulatory physiology. Better barrier resistance in cells, a stronger skin microvascular response and improved large-artery relaxation are not the same result. None of these experiments established fewer heart attacks or strokes.
The distinction between vitamin D status and vitamin D effect prevents overinterpretation: a blood concentration is not a direct measure of every tissue response. These findings support further investigation of endothelial mechanisms and carefully specified human outcomes. They do not define a supplement dose, a blood target or a proven cardiovascular treatment.
Scientific sources
Vila Cuenca M, Ferrantelli E, Meinster E, Pouw SM, Kovačević I, de Menezes RX, Niessen HW, Beelen RHJ, Hordijk PL, Vervloet MG. Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability. Journal of the American Heart Association. 2018;7(17):e008776. DOI: 10.1161/JAHA.118.008776. PMID: 30371149. Principal barrier experiment, including supplementary kidney-function and α-Klotho results.
Dreyer G, Tucker AT, Harwood SM, Pearse RM, Raftery MJ, Yaqoob MM. Ergocalciferol and Microcirculatory Function in Chronic Kidney Disease and Concomitant Vitamin D Deficiency: An Exploratory, Double Blind, Randomised Controlled Trial. PLoS ONE. 2014;9(7):e99461. DOI: 10.1371/journal.pone.0099461. PMID: 25006678. Human microcirculatory trial; its supplementary methods and study protocol inform the appraisal.
Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP. Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Hypertension. 2017;30(2):124-129. DOI: 10.1093/ajh/hpw135. PMID: 28077419. Human supplementation comparison.
Correction to Borgi and colleagues: Erratum. American Journal of Hypertension. 2017;30(7):731. DOI: 10.1093/ajh/hpx030. PMID: 28472334. Replaces Figure 3; the numerical comparison discussed here is reported in the article text.
Related reading
Vitamin D, Endothelial Barriers and Vascular Function: Full Study
Explore endothelial barrier experiments and human vitamin D trials, including kidney disease, vascular measurements, conflicting findings and clinical limits.
Read more →Vitamin D deficiency, endothelial function and bone biomarkers in post-kidney transplantation patients from North India
The prevalence of vitamin D deficiency in North Indian kidney transplantation patients and its impact on vascular and bone biomarkers is unknown which this study investigated.
Original paper ↗Read more →Beneficial Effects of Calcitriol on Hypertension, Glucose Intolerance, Impairment of Endothelium-Dependent Vascular Relaxation, and Visceral Adiposity in Fructose-Fed Hypertensive Rats
We investigated the effects of calcitriol, an active form of vitamin D, on vascular relaxation, glucose tolerance, and visceral fat pads in fructose-fed rats.
Original paper ↗Read more →Restoration of Vitamin D Levels Improves Endothelial Function and Increases TASK-Like K+ Currents in Pulmonary Arterial Hypertension Associated with Vitamin D Deficiency
Vitamin D (vitD) deficiency is highly prevalent in patients with pulmonary arterial hypertension (PAH).
Original paper ↗Read more →The Role of Vitamin D in Blood Pressure, Endothelial and Renal Function in Postmenopausal Women
Background: Vitamin D is a pro-hormone that plays an essential role in the vasculature and in kidney function.
Original paper ↗Read more →Changes in vascular structure and function in primary hyperparathyroidism: a systematic review and meta-analysis
Compared with controls, PHPT patients exhibited significantly increased carotid IMT and markedly reduced FMD, indicating early structural arterial changes and endothelial dysfunction.
Original paper ↗Read more →Effect of Vitamin D Status on Vascular Function of the Aorta in a Rat Model of PCOS
We aimed to investigate the role of vitamin D status on aortic function.
Original paper ↗Read more →Progression of endothelial dysfunction, atherosclerosis, and arterial stiffness in stable kidney transplant patients: a pilot study
This pilot study investigated changes in vascular abnormalities over time in stable kidney transplant patients long after transplantation.
Original paper ↗Read more →Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis
PubMed/Medline, Web of Science, Embase and Cochrane trials and reviews were searched systematically for randomized controlled trials (RCT:s) using any vitamin D compound, at any stage of CKD, with FMD as outcome.
Original paper ↗Read more →A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients
Clinical trial data demonstrating the benefits of vitamin D formulations are limited, and fail to show significant benefits on CV outcomes, and have compared different compounds, in various populations, and focused on a variety of outcomes.
Original paper ↗Read more →Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients
In this study, we investigated if elevated FGF23 association with severe AKI is mediated by several endothelial/glycocalyx-related biomarkers.
Original paper ↗Read more →Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway
We investigated the effects of sustained exposure to a high-phosphate environment on endothelial function in cellular and preclinical models, as well as in human subjects.
Original paper ↗Read more →Calcitriol Supplementation Ameliorates Microvascular Endothelial Dysfunction in Vitamin D-Deficient Diabetic Rats by Upregulating the Vascular eNOS Protein Expression and Reducing Oxidative Stress
The DC group had significantly lower acetylcholine-induced relaxation and augmented endothelium-dependent contraction, with reduced eNOS expression, compared to NR rats.
Original paper ↗Read more →Correlation between tear levels of vascular endothelial growth factor and vitamin D at retinopathy of prematurity stages in preterm infants
The purpose of this study was to correlate tear levels of VEGF and VIT-D with different ROP stages in preterm infants.
Original paper ↗Read more →The Role of Vitamin D in Modulating Mesenchymal Stem Cells and Endothelial Progenitor Cells for Vascular Calcification
Recent observations implied a role for mesenchymal stem cells and endothelial progenitor cells in vascular calcification.
Original paper ↗Read more →Effects of Parenteral Vitamin D on the Biomarkers of the Endothelial Function in Patients with Type 2 Diabetes and Ischemic Heart Disease: A Randomized Clinical Trial
We investigated whether a single parenteral dose of 25(OH) Vit D could improve the endothelial function in T2D patients with ischemic heart disease.
Original paper ↗Read more →Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults
Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups.
Original paper ↗Read more →Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound
The contribution of subclinical atheromatosis extent, including femoral arteries, to CVE in CKD patients has not been investigated.
Original paper ↗Read more →Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients
Cardiovascular events are frequent and vascular endothelial function is abnormal in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Nutrient patterns in relation to insulin resistance and endothelial dysfunction in Iranian women
We examined the association between various NPs and IR and endothelial dysfunction among Iranian women.
Original paper ↗Read more →Vitamin D deficiency causes inward hypertrophic remodeling and alters vascular reactivity of rat cerebral arterioles
After 8 weeks of treatment anterior cerebral artery segments were prepared and their morphological, biomechanical and functional properties were examined using pressure microangiometry.
Original paper ↗Read more →Original sources
Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability
Published in Journal of the American Heart Association (2018).
Publication details
Vila Cuenca M, Ferrantelli E, Meinster E, Pouw SM, Kovačević I, de Menezes RX, Niessen HW, Beelen RHJ, Hordijk PL, Vervloet MG. Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability. Journal of the American Heart Association. 2018;7(17):e008776. DOI: 10.1161/JAHA.118.008776. PMID: 30371149. Principal barrier experiment, including supplementary kidney-function and α-Klotho results.
Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial
Published in American Journal of Hypertension (2017).
Publication details
Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP. Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Hypertension. 2017;30(2):124-129. DOI: 10.1093/ajh/hpw135. PMID: 28077419. Human supplementation comparison.
Erratum
Published in American Journal of Hypertension (2017).
Publication details
Correction to Borgi and colleagues: Erratum. American Journal of Hypertension. 2017;30(7):731. DOI: 10.1093/ajh/hpx030. PMID: 28472334. Replaces Figure 3; the numerical comparison discussed here is reported in the article text.